Stock listing

A3E4QR Stock Price, News, Filings & Events — X4 Pharmaceuticals, Inc.

Selected listing: A3E4QR · LS · EUR · DE

This page tracks X4 Pharmaceuticals, Inc.'s A3E4QR:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3E4QR:LS. A3E4QR:LS is the stock-level entry point for investors researching X4 Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. X4 Pharmaceuticals, Inc. (ticker: XFOR) is a public company based in the United States, focusing on developing innovative therapies for rare diseases. With a market capitalization of approximately $360.3 million, X4 is dedicated to advancing its pipeline of treatments to improve patient outcomes. The company operates within the pharmaceutical sector, emphasizing research and development in its strategic initiatives.

A3E4QR:LSEURDEUpdated September 4, 2026
X4 Pharmaceuticals, Inc. logo
Ticker
A3E4QR:LS
Asset type
Stock
Market cap
$400.6M
Sector
Health Technology
Industry
Biotechnology
Exchange
LS
Currency
EUR

X4 Pharmaceuticals, Inc. A3E4QR:LS stock context

This page tracks X4 Pharmaceuticals, Inc.'s A3E4QR:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3E4QR:LS. A3E4QR:LS is the stock-level entry point for investors researching X4 Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. X4 Pharmaceuticals, Inc. (ticker: XFOR) is a public company based in the United States, focusing on developing innovative therapies for rare diseases. With a market capitalization of approximately $360.3 million, X4 is dedicated to advancing its pipeline of treatments to improve patient outcomes. The company operates within the pharmaceutical sector, emphasizing research and development in its strategic initiatives.

Latest news from X4 Pharmaceuticals, Inc.

All X4 Pharmaceuticals, Inc. news →

X4 Pharmaceuticals, Inc. earnings calls

Research X4 Pharmaceuticals, Inc.

Alternate listings